Therapeutic potential of co-signaling receptor modulation in hepatitis B
Cell · 2024-07 · 187 (15) · 4078-4094.e21
DOI: 10.1016/j.cell.2024.05.038 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cell, 2024-07. Verfasst von Francesco Andreata und 29 weiteren Autor:innen. Beteiligte Einrichtung: Division of Immunology, Transplantation, and Infectious Diseases, IRCCS San Raffaele Scientific Institute, Milan, Italy; Vita-Salute San Raffaele Uni…. Hauptthemen laut MEDLINE: CD8-Positive T-Lymphocytes, Hepatitis B, Chronic, Hepatitis B virus. Die Arbeit wurde bisher 58-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Associazione Italiana per la Ricerca sul Cancro, European Research Council, Ministero dell'Istruzione dell'Universita e della Ricerca.
Abstract (Originalsprache)
Reversing CD8+ T cell dysfunction is crucial in treating chronic hepatitis B virus (HBV) infection, yet specific molecular targets remain unclear. Our study analyzed co-signaling receptors during hepatocellular priming and traced the trajectory and fate of dysfunctional HBV-specific CD8+ T cells. Early on, these cells upregulate PD-1, CTLA-4, LAG-3, OX40, 4-1BB, and ICOS. While blocking co-inhibitory receptors had minimal effect, activating 4-1BB and OX40 converted them into antiviral effectors. Prolonged stimulation led to a self-renewing, long-lived, heterogeneous population with a unique transcriptional profile. This includes dysfunctional progenitor/stem-like (TSL) cells and two distinct dysfunctional tissue-resident memory (TRM) populations. While 4-1BB expression is ubiquitously maintained, OX40 expression is limited to TSL. In chronic settings, only 4-1BB stimulation conferred antiviral activity. In HBeAg+ chronic patients, 4-1BB activation showed the highest potential to rejuvenate dysfunctional CD8+ T cells. Targeting all dysfunctional T cells, rather than only stem-like precursors, holds promise for treating chronic HBV infection.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Immunology, Transplantation, and Infectious Diseases, IRCCS San Raffaele Scientific Institute, Milan, Italy; Vita-Salute San Raffaele University, Milan, Italy.
- Division of Immunology, Transplantation, and Infectious Diseases, IRCCS San Raffaele Scientific Institute, Milan, Italy; Vita-Salute San Raffaele University, Milan, Italy; Center for Omics Sciences, IRCCS San Raffaele S…
- Division of Immunology, Transplantation, and Infectious Diseases, IRCCS San Raffaele Scientific Institute, Milan, Italy.
- Laboratory of Viral Immunopathology, Unit of Infectious Diseases and Hepatology, Azienda Ospedaliero-Universitaria di Parma, Parma, Italy.
- Division of Immunology, Transplantation, and Infectious Diseases, IRCCS San Raffaele Scientific Institute, Milan, Italy; Center for Omics Sciences, IRCCS San Raffaele Scientific Institute, Milan, Italy.
- San Raffaele-Telethon Institute for Gene Therapy (SR-Tiget), Milan, Italy.
Förderung
- Associazione Italiana per la Ricerca sul Cancro
- European Research Council
- Ministero dell'Istruzione dell'Universita e della Ricerca
- Fondazione Cariplo
- Allos Therapeutics
- Vir Biotechnology
- European Molecular Biology Organization
- Japan Agency for Medical Research and Development
Zitieren
APA
Andreata, F., Laura, C., Ravà, M., Krueger, C. C., Ficht, X., Kawashima, K., Beccaria, C. G., Moalli, F., Partini, B., Fumagalli, V., Nosetto, G., Di Lucia, P., Montali, I., Garcia-Manteiga, J. M., Bono, E. B., Giustini, L., Perucchini, C., Venzin, V., Ranucci, S., …, & Iannacone, M. (2024). Therapeutic potential of co-signaling receptor modulation in hepatitis B. Cell, 187(15), 4078-4094.e21. https://doi.org/10.1016/j.cell.2024.05.038
Vancouver
Andreata F, Laura C, Ravà M, Krueger CC, Ficht X, Kawashima K, et al. Therapeutic potential of co-signaling receptor modulation in hepatitis B. Cell. 2024;187(15):4078-4094.e21. doi:10.1016/j.cell.2024.05.038
BibTeX
@article{Andreata2024,
author = {Andreata, Francesco and Laura, Chiara and Ravà, Micol and Krueger, Caroline C and Ficht, Xenia and Kawashima, Keigo and Beccaria, Cristian G and Moalli, Federica and Partini, Bianca and Fumagalli, Valeria and Nosetto, Giulia and Di Lucia, Pietro and Montali, Ilaria and Garcia-Manteiga, José M and Bono, Elisa B and Giustini, Leonardo and Perucchini, Chiara and Venzin, Valentina and Ranucci, Serena and Inverso, Donato and De Giovanni, Marco and Genua, Marco and Ostuni, Renato and Lugli, Enrico and Isogawa, Masanori and Ferrari, Carlo and Boni, Carolina and Fisicaro, Paola and Guidotti, Luca G and Iannacone, Matteo},
title = {Therapeutic potential of co-signaling receptor modulation in hepatitis B},
journal = {Cell},
year = {2024},
volume = {187},
number = {15},
pages = {4078--4094.e21},
doi = {10.1016/j.cell.2024.05.038}
}
EUVIMED